Please try another search
For the fiscal year ended 31 December 2017, Polypid Ltd revenues was not reported. Net loss applicable to common stockholders increased from $14M to $59.1M. Higher net loss reflects Revaluation of warrants increase from $1.2M to $40.8M (expense), Research and development, net - Balancin increase of 26% to $9.3M (expense), General and administrative - Balancing v increase of 37% to $3.1M (expense).
Period Ending: | Dec 31, 2017 | Sep 30, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -5.01 | -8.79 | -3.19 | -7.07 |
Net Income | -40.14 | -14.35 | -2.14 | -9.25 |
Period Ending: | Dec 31, 2017 | Sep 30, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Total Assets | 22.98 | 17.23 | ||
Total Liabilities | 51.65 | 14.8 | ||
Total Equity | -28.66 | 2.43 |
Period Ending: | Dec 31, 2017 | Sep 30, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Period Length: | 12 Months | 9 Months | 12 Months | 9 Months |
Cash From Operating Activities | -12.31 | -8.49 | -9.73 | -7.49 |
Cash From Investing Activities | -8.38 | -1.5 | -8.07 | -8.76 |
Cash From Financing Activities | 14.38 | 6.17 | 26.34 | 21.29 |
Net Change in Cash | -6.31 | -3.81 | 8.54 | 5.04 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review